Cargando…

Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells

Cancers are complex diseases having several unique features, commonly described as ‘hallmarks of cancer’. Among them, altered signaling pathways are the common characteristic features that drive cancer progression; this is achieved due to mutations that lead to the activation of growth promoting(s)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marbaniang, Casterland, Kma, Lakhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249467/ https://www.ncbi.nlm.nih.gov/pubmed/30255690 http://dx.doi.org/10.22034/APJCP.2018.19.9.2377

Ejemplares similares

Oncogenes and Tumor Suppressors Regulate Glutamine Metabolism in Cancer Cells
por: Kim, Min Hyun, et al.
Publicado: (2013)

SIRT3: Oncogene and Tumor Suppressor in Cancer
por: Torrens-Mas, Margalida, et al.
Publicado: (2017)

TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor
por: Matassa, Danilo Swann, et al.
Publicado: (2018)

RUNX family: Oncogenes or tumor suppressors
por: Otálora-Otálora, Beatriz Andrea, et al.
Publicado: (2019)

Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017)

Tumor-Suppressor Genes and Oncogenes
Publicado: (1993)

Oncogenes and tumor-suppressor genes.
por: Lehman, T A, et al.
Publicado: (1991)

NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors?
por: Huang, Tingting, et al.
Publicado: (2016)

Tumor suppressor and oncogenic role of long non-coding RNAs in cancer
por: Guzel, Esra, et al.
Publicado: (2019)

VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles
por: Cuadrado, Myriam, et al.
Publicado: (2021)

RhoB: Team Oncogene or Team Tumor Suppressor?
por: Ju, Julia A., et al.
Publicado: (2018)

Tumor Suppressors Having Oncogenic Functions: The Double Agents
por: Datta, Neerajana, et al.
Publicado: (2020)

Phytochemicals of Aristolochia tagala and Curcuma caesia exert anticancer effect by tumor necrosis factor-α-mediated decrease in nuclear factor kappaB binding activity
por: Hadem, Khetbadei Lysinia Hynniewta, et al.
Publicado: (2015)

Genetic Basis for Carcinogenesis. Tumor Suppressor Genes and Oncogenes
por: Rabbitts, P.
Publicado: (1992)

Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors
por: Bielli, Pamela, et al.
Publicado: (2019)

The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
por: de Cárcer, Guillermo
Publicado: (2019)

The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer
por: Kellenberger, L. D., et al.
Publicado: (2010)

Regulation of glucose metabolism by p53: Emerging new roles for the tumor suppressor
por: Madan, Esha, et al.
Publicado: (2011)

Myosin Heavy Chain 9: Oncogene or Tumor Suppressor Gene?
por: Wang, Yunmei, et al.
Publicado: (2019)

Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer
por: Inamura, Kentaro
Publicado: (2017)

Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer
por: Ye, Ting, et al.
Publicado: (2020)

KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview
por: Sobocińska, Joanna, et al.
Publicado: (2021)

USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma
por: Prieto-Garcia, Cristian, et al.
Publicado: (2021)

Analysis of Oncogenes and Tumor Suppressor Genes in Human Breast Cancer
por: Yamashita, Hiroko, et al.
Publicado: (1993)

Inhibitory potential of methanolic extracts of Aristolochia tagala and Curcuma caesia on hepatocellular carcinoma induced by diethylnitrosamine in BALB/c mice
por: Hadem, Khetbadei Lysinia Hynniewta, et al.
Publicado: (2014)

Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene?
por: Nasif, Daniela, et al.
Publicado: (2018)

The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors
por: Stehr, Henning, et al.
Publicado: (2011)

The Diverse Oncogenic and Tumor Suppressor Roles of microRNA-105 in Cancer
por: Li, Jie, et al.
Publicado: (2019)

Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.
por: Lechner, J F, et al.
Publicado: (1997)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?
por: Pickard, Adam, et al.
Publicado: (2015)

Somatic selection distinguishes oncogenes and tumor suppressor genes
por: Chandrashekar, Pramod, et al.
Publicado: (2019)

Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

Oncogenic and tumor suppressor function of MEIS and associated factors
por: GİRGİN, Birkan, et al.
Publicado: (2020)

Obesity‐dependent dysregulation of glucose homeostasis in kinase suppressor of ras 2(−/−) mice
por: Henry, MaLinda D., et al.
Publicado: (2014)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

Oncogenic regulation of tumor metabolic reprogramming
por: Tarrado-Castellarnau, Míriam, et al.
Publicado: (2016)

The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
por: Stachelscheid, Johanna, et al.
Publicado: (2021)

Oncogene or Tumor Suppressor: The Coordinative Role of Lysine Methyltransferase SET7/9 in Cancer Development and the Related Mechanisms
por: Gu, Ye, et al.
Publicado: (2022)

Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors
por: Krepischi, A. C. V., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sd4b71129ov5g9m5aq3qc4d821